Resplendent Aesthetics Med Spa and IV

Resplendent Aesthetics Med Spa and IV operates in Aurora, Colorado, providing peptide therapy, intravenous nutrient infusions, and aesthetic medicine services to patients throughout the Denver metropolitan area. The clinic addresses multiple wellness and cosmetic concerns through protocols that combine regenerative peptides with aesthetic procedures, targeting conditions ranging from age-related hormone decline to hair loss and chronic pain. With a 4.9-star rating across 74 Google reviews, the practice has established a reputation for individualized treatment planning and attentive patient care in the competitive Aurora medical aesthetics market.

The peptide therapy program at Resplendent Aesthetics centers on Sermorelin and NAD+ protocols. Sermorelin, a growth hormone-releasing hormone analog consisting of the first 29 amino acids of naturally occurring GHRH, is administered to patients experiencing decreased energy, reduced muscle mass, poor sleep quality, and metabolic slowdown associated with declining growth hormone production. The clinic's NAD+ therapy delivers nicotinamide adenine dinucleotide intravenously, supporting cellular energy production, DNA repair mechanisms, and mitochondrial function. These peptide treatments integrate with the clinic's weight loss programs, where patients receive comprehensive metabolic support combining peptide therapy with nutritional guidance and body composition monitoring. The Aurora facility also provides platelet-rich plasma treatments for hair restoration, addressing androgenetic alopecia and pattern hair loss through growth factor concentration from the patient's own blood, alongside hair transplant consultation services.

Resplendent Aesthetics approaches pain management through regenerative injection therapies and peptide protocols designed to modulate inflammation and support tissue repair. The clinic's aesthetic services extend beyond peptides to include neuromodulator injections such as Botox for dynamic wrinkle reduction, dermal fillers for volume restoration, and combination treatments that address multiple signs of facial aging simultaneously. IV therapy offerings provide hydration support, vitamin infusions, and targeted nutrient delivery for patients seeking recovery support, immune enhancement, or performance optimization. Each treatment plan begins with a clinical assessment to determine appropriate peptide dosing, injection frequency, and complementary therapies based on the patient's health history, current symptoms, and wellness objectives.

Patient feedback in Google reviews frequently references the clinic's attention to detail during consultations, the team's responsiveness to questions about treatment protocols, and the thoroughness of pre-treatment education regarding expected timelines and potential side effects. Patients undergoing weight loss programs note the structured approach to metabolic optimization, while those receiving hair restoration treatments describe clear communication about PRP preparation methods and transplant candidacy criteria. The Aurora location provides a clinical environment where patients receive both aesthetic and functional medicine services, allowing for coordinated care when addressing multiple concerns such as facial rejuvenation combined with metabolic support or hair restoration paired with nutritional optimization.

Resplendent Aesthetics Med Spa and IV serves Aurora, Denver, Centennial, and surrounding Colorado communities, offering appointment scheduling for initial peptide therapy consultations, aesthetic treatment planning sessions, and follow-up assessments to monitor treatment response. The clinic's integration of peptide protocols with established aesthetic procedures creates treatment pathways for patients seeking both cosmetic enhancement and underlying physiological support. New patients undergo health screening to determine candidacy for Sermorelin therapy, NAD+ infusions, and regenerative treatments, with ongoing monitoring to adjust peptide dosing and treatment frequency based on clinical response and laboratory markers when applicable.